Free cookie consent management tool by TermsFeed Policy Generator

Ensayos Clínicos

Phase IIIb randomized trial comparing irradiation plus long term adjuvant androgen deprivation with GnRH antagonist versus GnRH agonist plus flare protection in patients with very high risk localized or locally advanced prostate cancer. A joint study of the EORTC ROG and GUCG. Pegasus

Ficha Técnica

Investigador Principal

AMALIA PALACIOS EITO

Promotor

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER

ESTADO

ACTIVO

DEPARTAMENTO

Oncología Radioterápica

Código EudraCT: 2015-005098-19

Número protocolo: 1414-ROG-GUCG

Fecha Inicio: 2018-04-03

Fecha Fin: 2025-07-03